Adaptimmune Therapeutics
ADAP
#9328
Rank
$66.39 M
Marketcap
$0.26
Share price
-20.31%
Change (1 day)
-81.02%
Change (1 year)

Earnings for Adaptimmune Therapeutics (ADAP)

Earnings in 2024 (TTM): -$65.18 Million USD

According to Adaptimmune Therapeutics's latest financial reports the company's current earnings are $0.17 Billion USD. , an increase over its 2023 earnings that were of -$0.12 Billion USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Adaptimmune Therapeutics from 2016 to 2024

Annual earnings

Year Earnings Change
2024 -$65.18 Million-41.87%
2023 -$0.12 Billion-30.65%
2022 -$0.17 Billion-0.36%
2021 -$0.17 Billion21.62%
2020 -$0.14 Billion-4.55%
2019 -$0.14 Billion69%
2018 -$82.71 Million-7.47%
2017 -$89.39 Million24.71%
2016 -$71.68 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-$0.16 Billion 140.19%๐Ÿ‡บ๐Ÿ‡ธ USA
-$7.6 Million-88.34%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.26 Billion 286.58%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
$0.68 B-1,145.88%๐Ÿ‡บ๐Ÿ‡ธ USA